Tandem Diabetes Care, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-12-31 was -2.00 shares.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-09-30 was -219.64K shares.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-06-30 was 3.58K shares.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-03-31 was 240.47K shares.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 83.42K shares, a 25.63% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 112.17K shares, a 54.64% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 72.54K shares, a 74.12% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 280.27K shares, a 75.17% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 83.42K shares 10-K · filed 2026-02-19 | |
| 2024-12-31 | 112.17K shares 10-K · filed 2026-02-19 | |
| 2023-12-31 | 72.54K shares 10-K · filed 2026-02-19 | |
| 2022-12-31 | 280.27K shares 10-K · filed 2025-02-26 | |
| 2021-12-31 | 1.13M shares 10-K · filed 2024-02-21 | |
| 2020-12-31 | 2.34M shares 10-K · filed 2023-02-22 | |
| 2019-12-31 | 1.42M shares 10-K · filed 2021-02-24 | |
| 2018-12-31 | 136.04K shares 10-K · filed 2020-02-24 | |
| 2017-12-31 | -2.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 24.41K shares 10-K · filed 2019-02-26 |
| 2017-09-30 | -219.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | |
| 2017-06-30 | 3.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | |
| 2017-03-31 | 240.47K shares 10-Q · filed 2017-04-27 | |
| 2016-12-31 | 14.87K shares 10-K · filed 2018-03-01 | |
| 2015-12-31 | 243.54K shares 10-K · filed 2017-03-08 | |
| 2014-12-31 | 143.78K shares 10-K · filed 2016-02-24 | |
| 2013-12-31 | 9.91K shares 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |